Dr. Abhilasha Baharani

Consultant Uvea specialist, Neoretina Eyecare Institute, Hyderabad.

1 article

Dr. Abhilasha Baharani, MBBS, DNB, FRCS(Glasg), FICO, is a Senior Consultant and Uvea Specialist at Neoretina Eyecare Institute, Hyderabad. She has been practicing uveitis for the past 10 years. She completed her MBBS (2000-2006) from Kasturba Medical College, Mangalore, DNB Ophthalmology (2006-2009) from Aravind Eye Hospital, Tirunelveli, Tamil Nadu, Fellowship in Uveitis & Ocular Inflammation (2010) from Aravind Eye Hospital, Madurai, Tamil Nadu and Fellowship in Ocular Inflammatory Disease in Vitreoretinal disorders (2011) from the Royal Victoria Eye & Ear Hospital, Dublin, Ireland. She has passed the Advanced FICO (Fellow International Council of Ophthalmology) exam in 2011 and was conferred the FRCS (Glasgow, UK) in 2016. She is recipient of the Carl Herbort Award at the Uveitis Society of India Annual Conference 2012, Bhubaneshwar, India, Award of Distinction and Award of Merit at the International Ophthalmology Congress- Innovations and Challenges in Glaucoma and Uveitis, Singapore, 2014 and the Best Poster Podium Presentation for Uvea at the All India Ophthalmological Society Conference, 2019, Indore, India. She has published articles in National and International peer-reviewed journals. Her notable recent publications as first author are a review on choroidal imaging published in Survey of Ophthalmology (Baharani A, Errera M-H, Jhingan M et al, Choroidal imaging in uveitis: An update, Survey of Ophthalmology, Volume 67, Issue 4, 2022, Pages 965-990, https://doi.org/10.1016/j.survophthal.2022.01.001.), study on Ozurdex in TB intermediate uveitis (Baharani A, Reddy P RR, Patil PM. The Efficacy and Safety of Intravitreal Dexamethasone Implant as Anti-inflammatory Monotherapy in the Management of Tuberculosis-associated Intermediate Uveitis. Ocul Immunol Inflamm. 2021 :1-9. doi: 10.1080/09273948.2021.1986544.) and a chapter on Ocular Tuberculosis in the book OCT & OCTA in Retinal disorders (Wolters Kluwer).

  1. Articles 26 Jul 2022 7 min read

    HLA-B27 associated Acute Anterior Uveitis

    Introduction Acute anterior uveitis (AAU) results from a breakdown of the blood-aqueous barrier and acute inflammation of the iris and ciliary body. It is the most common form of uveitis encountered the world over. Keratic precipitates (KPs) are characteristic of AAU and represent inflammatory cells that deposit on the corneal endothelium due to the upregulation of adhesion molecules in response to local chemoattractant cytokines. The association between HLA (human leukocyte antigen)-B27, a human major histocompatibility complex (MHC), and its gamut of inflammatory diseases and HLA-B27 associated AAU was first described in 1973 and to date, it remains one of the strongest HLA-disease associations known. Epidemiology Though most epidemiological studies are based in tertiary referral centers and have a referral bias towards posterior and intermediate uveitis, anterior uveitis is the most common form of uveitis encountered in most parts of the world. HLA-B27 AAU comprises cases of acute a